Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer.
Yeonjin JeonUiree JoJongmoo HongGyungyub GongHee Jin LeePublished in: BMC cancer (2022)
TNBC showed similar TROP2 expression regardless of neoadjuvant treatment or primary tumor/metastasis. Although the prognostic significance of TROP2 expression in metastatic TNBC has been revealed, further evaluation of the predictive value of TROP2 expression for targeted therapy is needed.